Home  »  Science   »  During The Past Six Months, GoodRx Holdings Inc. (...

During The Past Six Months, GoodRx Holdings Inc. (NASDAQ: GDRX) Shares Took An 14.66% Jump. Here Is What We Should Expect

During the last session, GoodRx Holdings Inc. (NASDAQ:GDRX)’s traded shares were 1.23 million. At the end of the trading day, the stock’s price was $5.24, reflecting an intraday gain of 1.95% or $0.1. The 52-week high for the GDRX share is $10.37, that puts it down -97.9 from that peak though still a striking 27.1% gain since the share price plummeted to a 52-week low of $3.82. The company’s market capitalization is $2.10B, and the average intraday trading volume over the past 10 days was 1.07 million shares, and the average trade volume was 1.58 million shares over the past three months.

GoodRx Holdings Inc. (GDRX) received a consensus recommendation of a Hold from analysts. That translates to a mean rating of 2.60. GDRX has a Sell rating from 0 analyst(s) out of 22 analysts who have looked at this stock. 17 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.06.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


GoodRx Holdings Inc. (NASDAQ:GDRX) trade information

GoodRx Holdings Inc. (GDRX) registered a 1.95% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.95% in intraday trading to $5.24 this Thursday, 05/25/23, hitting a weekly high. The stock’s 5-day price performance is 1.95%, and it has moved by 7.82% in 30 days. Based on these gigs, the overall price performance for the year is -30.13%. The short interest in GoodRx Holdings Inc. (NASDAQ:GDRX) is 4.94 million shares and it means that shorts have 3.48 day(s) to cover.

The consensus price target of analysts on Wall Street is $6.41, which implies an increase of 18.25% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5.00 and $8.00 respectively. As a result, GDRX is trading at a discount of -52.67% off the target high and 4.58% off the low.

GoodRx Holdings Inc. (GDRX) estimates and forecasts

Statistics show that GoodRx Holdings Inc. has underperformed its competitors in share price, compared to the industry in which it operates. GoodRx Holdings Inc. (GDRX) shares have gone up 14.66% during the last six months, with a year-to-date growth rate less than the industry average at -16.67% against 4.30. In the rating firms’ projections, revenue will decrease -0.60% compared to the previous financial year.

Revenue for the current quarter is expected to be $186.68 million as predicted by 17 analyst(s). Meanwhile, a consensus of 17 analyst(s) estimates revenue growth to $192.47 million by the end of Sep 2023. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $191.8 million and $185.33 million respectively. In this case, analysts expect current quarter sales to shrink by -2.70% and then jump by 3.90% in the coming quarter.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -25.10%. While earnings are projected to return -29.10% in 2023, the next five years will return -0.01% per annum.

GDRX Dividends

GoodRx Holdings Inc. is due to release its next quarterly earnings on May 10. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

GoodRx Holdings Inc. (NASDAQ:GDRX)’s Major holders

GoodRx Holdings Inc. insiders own 6.15% of total outstanding shares while institutional holders control 63.89%, with the float percentage being 68.09%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 218 institutions own stock in it. As of Mar 30, 2023, the company held over 8.37 million shares (or 10.07% of all shares), a total value of $52.34 million in shares.

The next largest institutional holding, with 3.53 million shares, is of Silver Lake Group, LLC’s that is approximately 4.25% of outstanding shares. At the market price on Mar 30, 2023, these shares were valued at $22.08 million.

Also, the Mutual Funds coming in first place with the largest holdings of GoodRx Holdings Inc. (GDRX) shares are Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund. Data provided on Dec 30, 2022 indicates that Vanguard Total Stock Market Index Fund owns about 2.33 million shares. This amounts to just over 2.78 percent of the company’s overall shares, with a $10.87 million market value. The same data shows that the other fund manager holds slightly less at 1.81 million, or about 2.15% of the stock, which is worth about $8.41 million.

On Key

Related Posts